"We have generated revenues of over $100B and we have touched around 1.3B patients with our vaccines and medications. Pfizer (PFE) has completed acquisitions of Arena, Biohaven, Global Blood Therapeutics, and Reviral in 2022. I believe our Covid products will remain a multi-billion dollar revenue generators for the foreseeable future," says Pfizer CFO Dave Dentin.
31 Jan 2023
Market On Close
10 Jan 2023
Trading 360
03 Mar 2023
The Watch List
27 Feb 2023
Morning Trade Live
09 Mar 2023
The Watch List
14 Mar 2023
Trading 360
03 Feb 2023